Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Alzheimer's Disease

Free Subscription 15.04.2019 1 Alzheimer Dis Assoc Disord 1 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 Am J Psychiatry 1 BMJ 1 Brain Res 26 J Alzheimers Dis 1 J Neurochem 2 J Neurol 1 Lancet Neurol 2 N Engl J Med 1 Nat Rev Neurol 2 Neurobiol Aging 5 Neurology 1 Neuroreport 1 Neurosci Lett 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimer Dis Assoc Disord

1. GRILL JD, Nuno MM, Gillen DL
   Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
   Alzheimer Dis Assoc Disord. 2019 Apr 4. doi: 10.1097/WAD.0000000000000303.
   PubMed     Text format     Abstract available
   
   

   
   Alzheimers Dement

2. LLEO A, Alcolea D, Martinez-Lage P, Scheltens P, et al
   Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
   Alzheimers Dement. 2019 Apr 6. pii: S1552-5260(19)30047.
   PubMed     Text format     Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

3. TAKAHASHI M, Tada T, Nakamura T, Koyama K, et al
   Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET.
   Am J Alzheimers Dis Other Demen. 2019 Apr 9:1533317519841192.
   PubMed     Text format     Abstract available
   
   

   
   Am J Psychiatry

4. FARRELL M, Lichtenstein M, Crowley JJ, Filmyer DM, et al
   Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.
   Am J Psychiatry. 2018;175:400-407.
   PubMed     Text format    
   
   

   
   BMJ

5. MAKI PM, Girard LM, Manson JE
   Menopausal hormone therapy and cognition.
   BMJ. 2019;364:l877.
   PubMed     Text format    
   
   

   
   Brain Res

6. MA XH, Duan WJ, Mo YS, Chen JL, et al
   Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3beta pathway in SH-SY5Y cells.
   Brain Res. 2018;1690:1-11.
   PubMed     Text format     Abstract available
   
   

   
   J Alzheimers Dis

7. BARDACH SH, Jicha GA, Karanth S, Zhang X, et al
   Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants.
   J Alzheimers Dis. 2019 Apr 1. pii: JAD181159. doi: 10.3233/JAD-181159.
   PubMed     Text format     Abstract available
   
   
8. GUO H, Zhao Z, Zhang R, Chen P, et al
   Monocytes in the Peripheral Clearance of Amyloid-beta and Alzheimer's Disease.
   J Alzheimers Dis. 2019 Apr 3. pii: JAD181177. doi: 10.3233/JAD-181177.
   PubMed     Text format     Abstract available
   
   
9. SHI X, Ohta Y, Liu X, Shang J, et al
   Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer's Disease Model.
   J Alzheimers Dis. 2019 Apr 3. pii: JAD181218. doi: 10.3233/JAD-181218.
   PubMed     Text format     Abstract available
   
   
10. FARR SA, Roesler E, Niehoff ML, Roby DA, et al
    Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181240. doi: 10.3233/JAD-181240.
    PubMed     Text format     Abstract available
    
    
11. ROE CM, Stout SH, Rajasekar G, Ances BM, et al
    A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181242. doi: 10.3233/JAD-181242.
    PubMed     Text format     Abstract available
    
    
12. SPENCER BE, Jennings RG, Brewer JB
    Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181243. doi: 10.3233/JAD-181243.
    PubMed     Text format     Abstract available
    
    
13. REGALADO-REYES M, Furcila D, Hernandez F, Avila J, et al
    Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181263. doi: 10.3233/JAD-181263.
    PubMed     Text format     Abstract available
    
    
14. LI C, Duara R, Loewenstein DA, Izquierdo W, et al
    Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180231. doi: 10.3233/JAD-180231.
    PubMed     Text format     Abstract available
    
    
15. MARTINEZ JF, Trujillo C, Arevalo A, Ibanez A, et al
    Assessment of Conjunctive Binding in Aging: A Promising Approach for Alzheimer's Disease Detection.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181154. doi: 10.3233/JAD-181154.
    PubMed     Text format     Abstract available
    
    
16. JERNEREN F, Cederholm T, Refsum H, Smith AD, et al
    Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181148. doi: 10.3233/JAD-181148.
    PubMed     Text format     Abstract available
    
    
17. LI C, Li Y, Zheng L, Zhu X, et al
    Abnormal Brain Network Connectivity in a Triple-Network Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181097. doi: 10.3233/JAD-181097.
    PubMed     Text format     Abstract available
    
    
18. GOETGHEBEUR PJD, Wesnes KA, Targum SD
    D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181094. doi: 10.3233/JAD-181094.
    PubMed     Text format     Abstract available
    
    
19. YAN T, Wang Y, Weng Z, Du W, et al
    Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181049. doi: 10.3233/JAD-181049.
    PubMed     Text format     Abstract available
    
    
20. MARIZZONI M, Ferrari C, Macis A, Jovicich J, et al
    Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181016. doi: 10.3233/JAD-181016.
    PubMed     Text format     Abstract available
    
    
21. MUSTAPIC M, Tran J, Craft S, Kapogiannis D, et al
    Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180578. doi: 10.3233/JAD-180578.
    PubMed     Text format     Abstract available
    
    
22. PATRICK S, Corrigan R, Grizzani J, Mey M, et al
    Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180421. doi: 10.3233/JAD-180421.
    PubMed     Text format     Abstract available
    
    
23. KUMAR S, Srivastav S, Fatima M, Giri RS, et al
    A Synthetic Pro-Drug Peptide Reverses Amyloid-beta-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181273. doi: 10.3233/JAD-181273.
    PubMed     Text format     Abstract available
    
    
24. QIU Q, Shen L, Jia L, Wang Q, et al
    A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Abeta42/Abeta40 ratio.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181291. doi: 10.3233/JAD-181291.
    PubMed     Text format     Abstract available
    
    
25. CAO C, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181000. doi: 10.3233/JAD-181000.
    PubMed     Text format     Abstract available
    
    
26. FRISONI GB, Blin O, Bordet R
    One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI).
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190267. doi: 10.3233/JAD-190267.
    PubMed     Text format    
    
    
27. MIAO Y, Guo D, Li W, Zhong Y, et al
    Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190156. doi: 10.3233/JAD-190156.
    PubMed     Text format     Abstract available
    
    
28. PETUKHOVA EO, Mukhamedshina YO, Salafutdinov II, Garanina EE, et al
    Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190150. doi: 10.3233/JAD-190150.
    PubMed     Text format     Abstract available
    
    
29. COSTA AS, Guerini FR, Arosio B, Galimberti D, et al
    SNARE Complex Polymorphisms Associate with Alterations of Visual Selective Attention in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190147. doi: 10.3233/JAD-190147.
    PubMed     Text format     Abstract available
    
    
30. LI WW, Shen YY, Tian DY, Bu XL, et al
    Brain Amyloid-beta Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190056. doi: 10.3233/JAD-190056.
    PubMed     Text format     Abstract available
    
    
31. ROY U, Heredia-Munoz MT, Stute L, Hofling C, et al
    Degeneration of the Suprachiasmatic Nucleus in an Alzheimer's Disease Mouse Model Monitored by in vivo Magnetic Resonance Relaxation Measurements and Immunohistochemistry.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190037. doi: 10.3233/JAD-190037.
    PubMed     Text format     Abstract available
    
    
32. PYUN JM, Kang MJ, Yun Y, Park YH, et al
    APOE varepsilon4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190032. doi: 10.3233/JAD-190032.
    PubMed     Text format     Abstract available
    
    

    
    J Neurochem

33. MURAMATSU I, Uwada J, Yoshiki H, Sada K, et al
    Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
    J Neurochem. 2019 Apr 10. doi: 10.1111/jnc.14701.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

34. MANCA C, Rivasseau Jonveaux T, Roch V, Marie PY, et al
    Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Abeta42 concentration in the very high range: a prospective study.
    J Neurol. 2019 Apr 8. pii: 10.1007/s00415-019-09315.
    PubMed     Text format     Abstract available
    
    
35. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

36. 
    Jo Barnes.
    Lancet Neurol. 2018;17:667.
    PubMed     Text format    
    
    

    
    N Engl J Med

37. EGAN MF, Kost J, Voss T, Mukai Y, et al
    Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
    N Engl J Med. 2019;380:1408-1420.
    PubMed     Text format    
    
    
38. HENLEY D, Raghavan N, Sperling R, Aisen P, et al
    Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.
    N Engl J Med. 2019;380:1483-1485.
    PubMed     Text format    
    
    

    
    Nat Rev Neurol

39. LEMPRIERE S
    Birth of hippocampal neurons declines in Alzheimer disease.
    Nat Rev Neurol. 2019 Apr 5. pii: 10.1038/s41582-019-0182.
    PubMed     Text format    
    
    

    
    Neurobiol Aging

40. WEINER MW, Toga A, Harvey D, Donohue M, et al
    Response to Zywieck and Kirkby paper.
    Neurobiol Aging. 2018;69:298-299.
    PubMed     Text format    
    
    
41. WRIGHT SM, Jensen SL, Cockriel KL, Davis B, et al
    Association study of rs3846662 with Alzheimer's disease in a population-based cohort: the Cache County Study.
    Neurobiol Aging. 2019 Mar 15. pii: S0197-4580(19)30082.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

42. MEYER PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, et al
    INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2019 Apr 5. pii: WNL.0000000000007232.
    PubMed     Text format     Abstract available
    
    
43. LATTANZI S, Silvestrini M
    Reader response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    PubMed     Text format    
    
    
44. ARVANITAKIS Z, Capuano AW
    Author response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:732.
    PubMed     Text format    
    
    
45. HERSHEY LA, Lipton RB
    Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?
    Neurology. 2019 Apr 5. pii: WNL.0000000000007233.
    PubMed     Text format    
    
    
46. SIEGLER JE 3RD, Galetta S
    Editors' note: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    PubMed     Text format    
    
    

    
    Neuroreport

47. SHANG YY, Ma YJ, Zhang L, Wang LJ, et al
    Flavonoids extracted from leaves of Diospyros kaki regulates RhoA activity to rescue synapse loss and reverse memory impairment in APP/PS1 mice.
    Neuroreport. 2018;29:564-569.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

48. SHOZAWA H, Oguchi T, Tsuji M, Yano S, et al
    Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro.
    Neurosci Lett. 2018;677:19-25.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

49. KIM JE, Park JJ, Lee MR, Choi JY, et al
    Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response.
    PLoS One. 2019;14:e0215205.
    PubMed     Text format     Abstract available
    
    
50. ROBY DA, Ruiz F, Kermath BA, Voorhees JR, et al
    Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-beta burden in a mouse model of Alzheimer's disease.
    PLoS One. 2019;14:e0215004.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: